Amgen at 2013 European Cancer Congress | Amgen

Amgen at 2013 European Cancer Congress

Results from studies of marketed and pipeline products will be presented at the 2013 European Cancer Congress (ECCO), happening Sept. 27 to Oct. 1 in Amsterdam.

Abstracts are available on the European Cancer Congress website at

If you are at ECCO, stop by Amgen's booth #2300 to learn more about Amgen Oncology.

Follow Amgen on Twitter at to receive news updates during ECCO.

Sep. 30, 2013 News Release: Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
Sep. 28, 2013 News Release: Phase 3 Trial Comparing Vectibix® (Panitumumab) to Erbitux® (Cetuximab) Meets Primary Endpoint Of Non-Inferiority Of Overall Survival
Sept. 12, 2013 News Release: Amgen Highlights Data to be Presented at 2013 European Cancer Congress

Share This Story